Skip to main content
. 2022 Nov 15;13:1040999. doi: 10.3389/fphar.2022.1040999

FIGURE 9.

FIGURE 9

Graphical abstract. In ob/ob mice model, ponatinib inhibits obesity-induced adipose tissue macrophage inflammatory transformation, thereby inhibiting obesity adipose tissue inflammation and insulin resistance, accompanied by amelioration of ectopic lipid deposition in peripheral blood and liver.